ClinConnect ClinConnect Logo
Search / Trial NCT05264935

Ultrasound-guided Lavage of Calcific Deposits of the Rotator Cuff

Launched by SCHULTHESS KLINIK · Feb 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Calcific Deposit Ultrasound Guided Puncture And Lavage Power Doppler Ultrasound

ClinConnect Summary

This clinical trial is looking at a procedure called ultrasound-guided lavage, which is a way to clean out calcific deposits in the shoulder that can cause pain and limit movement. Specifically, the study aims to see how well this technique works for patients with rotator cuff tendinitis, a condition that often leads to pain in the upper arm and shoulder, especially when lifting the arm or at night. Researchers will monitor changes in ultrasound images to understand how the calcific deposits and the tendon itself are healing over time, as well as how patients feel after the treatment.

To be eligible for this trial, participants must be at least 18 years old and have pain in their shoulder due to a specific type of calcific deposit. They should have already tried other treatments, like physical therapy and anti-inflammatory medication, without improvement. It's also important that participants can understand the study information in German and agree to take part. Those with certain other shoulder issues or previous treatments in the last three months may not qualify. If you join this study, you can expect to receive the ultrasound-guided lavage treatment and follow-up assessments to track your recovery and symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient aged 18 years and older
  • Pain in the deltoid region worsening with activities above shoulder level and/or at night with a calcific deposit
  • Ultrasound evaluation of the calcific deposit with type I or II characteristics, a solitary conformation, a minimum size of 1.0 x 0.5 x 0.4cm (length x width x depth) and without clear signs of resorption (PDUS grade 0 - I°, see study procedure).
  • In case of multiple calcific deposits, it has to be warranted that the other deposits are smaller than the minimum size of 1.0 x 0.5 x 0.4cm and with no signs of PDUS signals.
  • Qualification for more intensive treatment on account of no clinical improvement after a minimum of 3 months with conservative treatment (physical therapy and oral anti-inflammatory drugs).
  • able to understand the content of the patient information / consent form in German and give consent to take part in the project
  • Exclusion Criteria:
  • Previous UGPL or surgery of the affected shoulder
  • Treatment with subacromial injection (SAI) or ESWT in the three months before inclusion
  • Other causes of shoulder complaints (e.g. rotator cuff tear, frozen shoulder, inflammatory arthritis, bursitis, ...)
  • Intervention failure (no retrieval of calcific material, leakage of the injected saline, disruption of the calcific rim or distribution of calcific material)
  • Patients with a language barrier hindering questionnaire completion
  • Pregnancy

About Schulthess Klinik

Schulthess Klinik is a renowned medical institution based in Zurich, Switzerland, specializing in orthopedic surgery and rehabilitation. With a commitment to advancing patient care through innovative research and clinical trials, the clinic is dedicated to enhancing treatment outcomes and improving quality of life for individuals with musculoskeletal conditions. Schulthess Klinik combines state-of-the-art technology with a multidisciplinary approach, fostering collaborations among healthcare professionals to ensure comprehensive care and support for patients. Its reputation for excellence in clinical research positions Schulthess Klinik as a leader in the field, contributing valuable insights to the global medical community.

Locations

Zürich, , Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials